- $27.12bn
- $40.71bn
- $25.97bn
- 94
- 85
- 84
- 99
Annual balance sheet for Nutrien, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,454 | 499 | 901 | 941 | 853 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,581 | 5,366 | 6,194 | 5,398 | 5,390 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 11,470 | 13,846 | 16,342 | 14,170 | 13,792 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 19,660 | 20,016 | 21,767 | 22,461 | 22,604 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 47,192 | 49,954 | 54,586 | 52,749 | 51,840 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8,480 | 12,443 | 14,280 | 12,121 | 12,045 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 24,827 | 26,302 | 28,768 | 27,593 | 27,433 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 22,365 | 23,652 | 25,818 | 25,156 | 24,407 |
| Total Liabilities & Shareholders' Equity | 47,192 | 49,954 | 54,586 | 52,749 | 51,840 |
| Total Common Shares Outstanding |